Achilles Therapeutics plc (ACHL)
Mar 20, 2025 - ACHL was delisted pending liquidation
1.480
0.00 (0.00%)
Inactive · Last trade price on Mar 21, 2025

Achilles Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Buy
Price Target
$4.00
Upside
+170.27%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Piper Sandler
Piper Sandler
Hold
Downgrades
$8$2
HoldDowngrades$8$2+35.14%Apr 5, 2024
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$11$6
Strong BuyMaintains$11$6+305.41%Apr 5, 2024
B of A Securities
B of A Securities
Sell
Downgrades
$7$0.5
SellDowngrades$7$0.5-66.22%Dec 14, 2023
Chardan Capital
Chardan Capital
Strong Buy
Reiterates
$11
Strong BuyReiterates$11+643.24%Aug 7, 2023
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$12$11
Strong BuyMaintains$12$11+643.24%May 11, 2023
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$20$17
Strong BuyMaintains$20$17+1,048.65%Dec 7, 2022
Piper Sandler
Piper Sandler
Buy
Maintains
$10$8
BuyMaintains$10$8+440.54%Dec 7, 2022
JP Morgan
JP Morgan
Sell
Initiates
$11
SellInitiates$11+643.24%Apr 26, 2021
Chardan Capital
Chardan Capital
Strong Buy
Initiates
$27
Strong BuyInitiates$27+1,724.32%Apr 26, 2021
Piper Sandler
Piper Sandler
Buy
Initiates
$25
BuyInitiates$25+1,589.19%Apr 26, 2021
Oppenheimer
Oppenheimer
Buy
Initiates
$23
BuyInitiates$23+1,454.05%Apr 26, 2021